METiS Therapeutics

METiS Therapeutics

制药业

Cambridge,MA 1,728 位关注者

Redefining drug discovery and delivery with a data-driven platform to develop best-in-class treatments

关于我们

The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection and formulation design. Founded by a team of MIT researchers, serial entrepreneurs and biotech industry veterans, METiS develops and in-licenses novel assets with high therapeutic potential that could benefit from its data-driven platform.

网站
http://www.metistx.com
所属行业
制药业
规模
2-10 人
总部
Cambridge,MA
类型
私人持股

地点

METiS Therapeutics 员工

相似主页

融资